+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

COVID-19 Vaccine: Clinical Trials

COVID-19 Vaccine Candidates Enter Human Testing

There are more than 100 coronavirus vaccines in development with at least 20 expected to begin human testing in 2020. The pandemic has created an urgent need for a vaccine and pharmaceutical companies are working to accelerate the development process to meet demand. The research team from Oxford University had previously developed an effective vaccine against a related coronavirus Middle East Respiratory Syndrome (MERS) and this has helped them to quickly move into phase 1 human testing of their COVID-19 candidate. In January, the team began adapting their technique to fight SARS-CoV-2, the virus that causes COVID-19. Human trials began on April 23rd in the UK and if successful the vaccine could be available as early as September.

CanSino Biologics is currently conducting human trials of a similar viral vector vaccine in China while Pfizer and BioNTech have been authorized to begin human testing of their four mRNA vaccine candidates in Germany. In April, Innovio Pharmaceuticals announced that they have begun human trials of their DNA vaccine with results expected in June. Meanwhile, Moderna Therapeutics, one of the first companies to begin human testing of their COVID-19 vaccine candidate, recently announced that its phase 1 human trials are continuing on schedule while phase 2 human trials are expected to begin in spring.

We have included a selection of our most popular market research on COVID-19 vaccines below.

Intro Image
Global Coronavirus Vaccines Pipeline 2020

1

Global Coronavirus Vaccines Pipeline 2020

  • ID: 5021681
  • Report
  • 200 Pages
  • Region: Global
  • IMAPAC
Novel Coronavirus (COVID-19): Preventive Vaccines, Therapeutics and Diagnostics in Development

2

Novel Coronavirus (COVID-19): Preventive Vaccines, Therapeutics and Diagnostics in Development

  • ID: 4991025
  • Report
  • 137 Pages
  • Region: Global
  • Roots Analysis
Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline

4

Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline

  • ID: 5018694
  • Report
  • 182 Pages
  • Region: Global
  • Kalorama Information
Coronavirus (COVID-19) Vaccine Pipeline Assessment 2020

5

Coronavirus (COVID-19) Vaccine Pipeline Assessment 2020

  • ID: 5021674
  • Report
  • 135 Pages
  • Region: Global
  • DPI Research

Have a question?

We will help you find what you are looking for.

Call: 1-800-526-8630

adroll